BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11808525)

  • 1. Screening for Down's syndrome. Nuchal translucency screening may help detect congenital heart disease.
    Simpson JM
    BMJ; 2002 Jan; 324(7329):112. PubMed ID: 11808525
    [No Abstract]   [Full Text] [Related]  

  • 2. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of fetuses with increased nuchal translucency.
    Bilardo CM; Müller MA; Pajkrt E
    Curr Opin Obstet Gynecol; 2001 Apr; 13(2):169-74. PubMed ID: 11315872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does nuchal translucency have a role in fetal cardiac screening?
    Hyett J
    Prenat Diagn; 2004 Dec; 24(13):1130-5. PubMed ID: 15614845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First trimester screening for structural fetal abnormalities: nuchal translucency sonography.
    Devine PC; Malone FD
    Semin Perinatol; 1999 Oct; 23(5):382-92. PubMed ID: 10551791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distribution of nuchal translucency at 10-13 weeks of pregnancy.
    Schuchter K; Wald N; Hackshaw AK; Hafner E; Liebhart E
    Prenat Diagn; 1998 Mar; 18(3):281-6. PubMed ID: 9556045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome.
    Wald NJ; Hackshaw AK
    Prenat Diagn; 1997 Sep; 17(9):821-9. PubMed ID: 9316126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
    Müller MA; Clur SA; Timmerman E; Bilardo CM
    Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal nuchal translucency and normal chromosomes: a long-term follow-up study.
    Hiippala A; Eronen M; Taipale P; Salonen R; Hiilesmaa V
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):18-22. PubMed ID: 11489219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of ethnic origin on nuchal translucency screening for Down's syndrome.
    Thilaganathan B; Khare M; Williams B; Wathen NC
    Ultrasound Obstet Gynecol; 1998 Aug; 12(2):112-4. PubMed ID: 9744055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
    Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
    Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency.
    Hafner E; Schuchter K; Philipp K
    Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
    Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
    Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuchal translucency and congenital heart defects: heart failure or not?
    Simpson JM; Sharland GK
    Ultrasound Obstet Gynecol; 2000 Jul; 16(1):30-6. PubMed ID: 11084962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
    McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
    Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down's syndrome screening with nuchal translucency.
    Hackshaw AK; Wald NJ; Haddow JE
    Lancet; 1996 Dec 21-28; 348(9043):1740. PubMed ID: 8973459
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    BJOG; 2004 Jun; 111(6):521-31. PubMed ID: 15198778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.